Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 12/20 | 0.69 |
| ▸ | CES1 | P23141 | 10/20 | 0.69 |
| ▸ | CES2 | O00748 | 5/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.48 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28049748 | 1.00 | FAAH (0.69) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL28049745 | 1.00 | FAAH (0.69) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL9059827 | 0.98 | FAAH (0.68) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL10489215 | 0.88 | FAAH (0.64) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL28687905 | 0.84 | FAAH (0.55) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL17943250 | 0.83 | FAAH (0.65) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL31152148 | 0.82 | FAAH (1.00) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL9192692 | 0.82 | FAAH (1.00) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL28471077 | 0.82 | FAAH (1.00) | FAAHCES1CES2MEN1CYP1A2 | |
| SCHEMBL10966855 | 0.82 | FAAH (1.00) | FAAHCES1CES2MEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048727-A1 | PERFLUOROKETONE COMPOUNDS AND USES THEREOF | DAVID SAMUEL | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048727-A1 | PERFLUOROKETONE COMPOUNDS AND USES THEREOF | PLA2G1B, PLA2G4B, PLA2G2E | FAAH 26/4885CES1 428/4885CES2 690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.